Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gum Arabic in postmenopausal females with metabolic syndrome
NCT04978103Phase 2Completed
- Sponsor
- University of Khartoum
- Start
- Dec 2019
- Primary completion
- Jan 2021
- Countries
- 1
01
Overview
Phase 2, open-label trial in metabolic syndrome, sponsored by University of Khartoum. Primary endpoints: Nuclear Factor Kappa Beta at 12 weeks, P38 Mitogen Activated Protein Kinase at 12 weeks and 2 more. Started Dec 2019; status: completed.
02
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT04978103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04978103.